Article
The evolutionary trajectories of P. aeruginosa in biofilm and planktonic growth modes exposed to ciprofloxacin: beyond selection of antibiotic resistance.
NPJ biofilms and microbiomes - 24 Jul 2020
Ahmed Marwa N, Abdelsamad Ahmed, Wassermann Tina, Porse Andreas, Becker Janna, Sommer Morten O A, Høiby Niels, Ciofu Oana
Abstract excerpt
Ciprofloxacin (CIP) is used to treat Pseudomonas aeruginosa biofilm infections. We showed that the pathways of CIP-resistance development during exposure of biofilms and planktonic P. aeruginosa populations to subinhibitory levels of CIP depend on the mode of growth. In the present study, we analyzed CIP-resistant isolates obtained from previous evolution experiments, and we report a variety of evolved phenotypic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
